(RTTNews) - NVIDIA (NVDA) and Marvell Technology (MRVL) announced a strategic partnership to connect Marvell to the NVIDIA AI factory and AI-RAN ecosystem through NVIDIA NVLink Fusion, offering customers building on NVIDIA architectures choice and flexibility in developing next-g
(RTTNews) - NVIDIA (NVDA) and Marvell Technology (MRVL) announced a strategic partnership to connect Marvell to the NVIDIA AI factory and AI-RAN ecosystem through NVIDIA NVLink Fusion, offering customers building on NVIDIA architectures choice and flexibility in developing next-g
Despite Tumbling Rates, US Home Price Acceleration Slowed In January US home price acceleration slowed significantly in January (according to the always lagged and smoothed Case-Shiller indices). After rising 0.50% MoM in December, the price of homes in America's to 20 cities rose just 0.16% MoM in January (the lowest MoM rise since August and well below the 0.35% MoM expected)... Source: Bloomber...
Despite Tumbling Rates, US Home Price Acceleration Slowed In January US home price acceleration slowed significantly in January (according to the always lagged and smoothed Case-Shiller indices). After rising 0.50% MoM in December, the price of homes in America's to 20 cities rose just 0.16% MoM in January (the lowest MoM rise since August and well below the 0.35% MoM expected)... Source: Bloomberg This left the 20-city composite index up just 1.18% YoY - the lowest since July 2023. "Price levels remain elevated, but the rate of appreciation has slowed materially," according to Nicholas Godec, CFA, CAIA, CIPM, Head of Fixed Income Tradables & Commodities at S&P Dow Jones Indices. . "Splitting the year into two halves sharpens the picture," Godec continued. "The National Index rose 2.2% over the first six months of the period, then fell 1.3% over the most recent six - a swing that explains why annual gains have compressed to under 1% despite prices remaining historically elevated. "Geographic leadership remains narrow," Godec concluded. New York leads with a 4.9% annual gain, followed by Chicago at 4.6% and Cleveland at 3.6%, while Tampa fell 2.5%... However, declining mortgage rates since suggest a rebound in aggregate prices could be about to explode... ...before the recent rise in rates kicks in (remember case-shiller data is very lagged). Is this what President Trump wants to see? Flat prices and lower mortgage rates means more affordability... credittrader Tue, 03/31/2026 - 09:09
Platinum Asset Management, an investment management company, released its Q4 2025 investor letter for “Platinum International Technology Fund”. A copy of the letter can be downloaded here. The fund was up 3% in the fourth quarter and 13.1% for calendar 2025, surpassing the benchmark return of 2.5% and 12.4%, respectively. U.S. Dollar depreciation negatively impacted […]
Platinum Asset Management, an investment management company, released its Q4 2025 investor letter for “Platinum International Technology Fund”. A copy of the letter can be downloaded here. The fund was up 3% in the fourth quarter and 13.1% for calendar 2025, surpassing the benchmark return of 2.5% and 12.4%, respectively. U.S. Dollar depreciation negatively impacted […]
Taiwan Semiconductor Manufacturing Company Limited (TSM) Gains from Strong Demand and Its Industry-Leading Manufacturing Capabilities uk.finance.yahoo.com
Taiwan Semiconductor Manufacturing Company Limited (TSM) Gains from Strong Demand and Its Industry-Leading Manufacturing Capabilities uk.finance.yahoo.com
Shares of Agios Pharmaceuticals ( AGIO ) rose ~14% on Tuesday after the company announced plans to seek U.S. accelerated approval for a label expansion of its lead product, Pyrukynd, in sickle cell disease. The decision came after the FDA, during a pre-supplemental New Drug Application (sNDA) meeting, recommended the company submit a proposal for a confirmatory clinical trial that can support a po...
Shares of Agios Pharmaceuticals ( AGIO ) rose ~14% on Tuesday after the company announced plans to seek U.S. accelerated approval for a label expansion of its lead product, Pyrukynd, in sickle cell disease. The decision came after the FDA, during a pre-supplemental New Drug Application (sNDA) meeting, recommended the company submit a proposal for a confirmatory clinical trial that can support a potential accelerated nod for mitapivat in SCD. Massachusetts-based Agios ( AGIO ) currently markets the oral pyruvate kinase activator, also known as mitapivat, for adults with blood disorders, pyruvate kinase deficiency, and thalassemia. The company stated that it has already submitted its proposal for the confirmatory trial for regulatory review, after which it plans to submit the sNDA for sickle cell disease in the months ahead. However, Agios ( AGIO ) noted that the proposed trial will not impact its previously disclosed outlook for 2026 operating expenses, which is estimated to remain roughly unchanged compared to the prior year. More on Agios Pharmaceuticals Agios Pharmaceuticals: Worthy Of Accumulation Agios Pharmaceuticals, Inc. 2025 Q4 - Results - Earnings Call Presentation Agios Pharmaceuticals, Inc. (AGIO) Q4 2025 Earnings Call Transcript Agios outlines path to profitability and targets $45M-$50M in 2026 PK deficiency revenue as AQVESME U.S. launch progresses Agios Pharmaceuticals Q4 2025 Earnings Preview
In this article .KS11 .STOXX XAU= @HG.1 .DXY Follow your favorite stocks CREATE FREE ACCOUNT A trader works on the floor of the New York Stock Exchange during morning trading on March 25, 2026 in New York City. Michael M. Santiago | Getty Images Stocks, bonds, currencies and commodities have all been gripped by volatility over the course of the past month, with many assets seeing wild swings and m...
In this article .KS11 .STOXX XAU= @HG.1 .DXY Follow your favorite stocks CREATE FREE ACCOUNT A trader works on the floor of the New York Stock Exchange during morning trading on March 25, 2026 in New York City. Michael M. Santiago | Getty Images Stocks, bonds, currencies and commodities have all been gripped by volatility over the course of the past month, with many assets seeing wild swings and major losses as the U.S.-Iran war drags on. While there have been some outliers, bearish sentiment has largely dragged assets lower over the course of the month. Equities Equities across the globe have been dragged into a bruising sell-off in the five weeks of war between the U.S. and Iran. On Wall Street, all three major averages are on course to end the month in negative territory. But the sell-off has had much deeper implications for many markets beyond New York, with the outperformance achieved by some international indices last year now upended. Concerns about the Iran war's impact on energy and inflation have weighed on sentiment toward markets in Europe and Asia, which are far more dependent than the U.S. on oil and gas imports. South Korea, for example, has seen its Kospi index — the top-performing stock market of 2025 — fall by almost 20% in March, thanks to the country's sensitivity to energy shocks . In a Monday note, strategists at Goldman Sachs said the "balance of risks has worsened" for equity markets and the probability of a stagflationary outcome has increased. "Stagflation has historically been a poor environment for equities, characterised by low real performance and elevated volatility: the median real quarterly Stoxx 600 return falls to around -1%, compared with +3% in non‑stagflation periods," they said. "We do not think the market is fully pricing stagflation. Under stagflation, we would expect further equity downside and weak real returns." Dan Coatsworth, head of markets at AJ Bell, shared three tips on trading a falling market in a note earlier this...
Walter Cicchetti/iStock Editorial via Getty Images Shares of Sysco ( SYY ) plunged following the news that the company announced a massive deal to acquire Jetro Restaurant Depot in a deal valued at nearly $30 billion. Investors fear the change in strategic direction, as Sysco is buying an attractive and higher-margin peer operating in a decent market, yet the issue is that the company will see a m...
Walter Cicchetti/iStock Editorial via Getty Images Shares of Sysco ( SYY ) plunged following the news that the company announced a massive deal to acquire Jetro Restaurant Depot in a deal valued at nearly $30 billion. Investors fear the change in strategic direction, as Sysco is buying an attractive and higher-margin peer operating in a decent market, yet the issue is that the company will see a massive increase in leverage. Some strategic questions, leverage incurred, and general jitteriness about the large deal created a massive sell-off in the share price. While that looks appealing in isolation, I am hard-pressed to buy the dip today but am keen on getting involved in further setbacks here. Other, higher conviction ideas, including recent M&A action, can be found at Value In Corporate Events . A Large Deal Sysco has reached a deal to acquire premier Cash & Carry food wholesaler Jetro Restaurant Depot in what the company calls a transformative deal. The company touts the strategic rationale of entering a high-margin, growing, and resilient Cash & Carry channel. Deal terms call for a $21.6 billion cash component and 91.5 million shares of Sysco to be issued to investors in Jetro. Valued at $81.80 per share ahead of the news, this translates into a $29.1 billion deal, valuing the business at 14.6 times operating income, seen around $2.0 billion each year. The company runs 166 large-format warehouse stores across 35 states to serve over 700,000 independent restaurants and foodservice operators with fresh and low-priced goods, with clients seeking delivery and white glove service. These are generally lucrative operations, with $2.1 billion in EBITDA reported on $16 billion in sales, valuing the operations at 1.8 times sales, these carrying healthy 13% EBITDA margins. The company sees about $250 million in synergies in three years post-closing, equal to about 12.5% of operating income acquired, driven by procurement gains and supply chain optimization. This modeling e...
Eightco Holdings ( ORBS ) announced that as of March 30, its assets include ~277.22M Worldcoin (WLD-USD) at $0.28 each, 11.07K Ethereum ( ETH-USD ), stakes worth $90M in OpenAI and $25M in Beast Industries, along with $109M in cash and stablecoins. The company's total holdings reach ~$326M. About 30% of its treasury is linked to OpenAI, and it holds nearly 9% of the circulating WLD supply. Moreove...
Eightco Holdings ( ORBS ) announced that as of March 30, its assets include ~277.22M Worldcoin (WLD-USD) at $0.28 each, 11.07K Ethereum ( ETH-USD ), stakes worth $90M in OpenAI and $25M in Beast Industries, along with $109M in cash and stablecoins. The company's total holdings reach ~$326M. About 30% of its treasury is linked to OpenAI, and it holds nearly 9% of the circulating WLD supply. Moreover, it had previously secured $130M in new funding, led by Bitmine ($80M), with ARK Invest and Kraken’s parent Payward investing ($25M) each. More on Eightco Holdings Eightco Holdings: Worldcoin, OpenAI, And POH Assets Are Overshadowed By Dilution Eightco boosts OpenAI investment by $40M to $90M Bitmine Immersion Technologies says ETH Holdings reach 4.596M tokens Financial information for Eightco Holdings